JIA in 2011: New takes on categorization and treatment.
In 2011, new treatment recommendations for juvenile idiopathic arthritis (JIA) were proposed, inroads were made towards understanding the heterogeneity of this disease, and data were presented demonstrating the potential efficacy of DMARD combination therapies for JIA treatment. These advances hold promise for improved management of JIA in 2012 and beyond.
University of Genoa, Pediatria II e Reumatologia, Istituto G. Gaslini, Largo G. Gaslini 5, 16147 Genoa, Italy. albertomartini@ospedale-gaslini.ge.it
Alberto
A
Martini
D000293:Adolescent; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001171:Arthritis, Juvenile / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy; D002648:Child; D004359:Drug Therapy, Combination; D006801:Humans
D018501:Antirheumatic Agents